Exploring the therapeutic potency of cryptotanshinone in cervical cancer: a multi-omics and network pharmacology approach.

Differential expression of the same three genes in these groups was illustrated in a comparison figure ( Figure 7B ), indicating a highly significant variation in IDO1 expression between high- and low-risk groups ( p < 0.001), with CA2 and TNF also showing significant differences ( p < 0.05).

also in 132,142 other papers